DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Davis AJ, Gelmon KA, Siu LL. et al.
Phase I and pharmacologic study of the human DNA methyltransferase antisense oligodeoxynucleotide MG98 given as a 21-day continuous infusion every 4 weeks.
Invest New Drugs 2003; 21: 85-97
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.